×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
WST – west pharmaceutical services, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
WST
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/29
06:00 am
wst
West to Host Fourth-Quarter and Full-Year 2025 Conference Call
Medium
Report
West to Host Fourth-Quarter and Full-Year 2025 Conference Call
1/26
10:12 am
wst
Time To Buy The Dip In West Pharmaceutical Stock? [Forbes]
Low
Report
Time To Buy The Dip In West Pharmaceutical Stock? [Forbes]
1/23
07:38 am
wst
Does West Pharmaceutical (WST) Expanding Into Biologic Syringe Systems Reshape Its Combination-Product Edge? [Yahoo! Finance]
Medium
Report
Does West Pharmaceutical (WST) Expanding Into Biologic Syringe Systems Reshape Its Combination-Product Edge? [Yahoo! Finance]
1/23
06:57 am
wst
West Pharmaceutical Services (NYSE:WST) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Medium
Report
West Pharmaceutical Services (NYSE:WST) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
1/20
06:00 am
wst
West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack
Low
Report
West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack
1/19
08:30 am
wst
Upslope Capital Management Exited West Pharmaceutical (WST) for Better Opportunities [Yahoo! Finance]
Medium
Report
Upslope Capital Management Exited West Pharmaceutical (WST) for Better Opportunities [Yahoo! Finance]
1/13
04:06 am
wst
West Pharmaceutical Services (NYSE:WST) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
West Pharmaceutical Services (NYSE:WST) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.
1/12
06:00 am
wst
West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie
Low
Report
West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie
Date
Time
Symbol
Company Name
Action
%Chg
10/23/2025
06:00 am
WST
west pharmaceutical services, inc.
BEAT
Report
2.4%
west pharmaceutical services, inc.
7/24/2025
06:00 am
WST
west pharmaceutical services, inc.
BEAT
Report
22.8%
west pharmaceutical services, inc.
4/24/2025
06:00 am
WST
west pharmaceutical services, inc.
BEAT
Report
-5.6%
west pharmaceutical services, inc.
2/13/2025
06:00 am
WST
west pharmaceutical services, inc.
BEAT
Report
-37.8%
west pharmaceutical services, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/5
12:37 pm
wst
Form 4 WEST PHARMACEUTICAL SERV For: Dec 31 Filed by: HAUGEN JANET BRUTSCHEA
Low
Report
Form 4 WEST PHARMACEUTICAL SERV For: Dec 31 Filed by: HAUGEN JANET BRUTSCHEA
12/10
10:34 am
wst
Form 4 WEST PHARMACEUTICAL SERV For: Dec 08 Filed by: Finch Norman D. Jr.
Low
Report
Form 4 WEST PHARMACEUTICAL SERV For: Dec 08 Filed by: Finch Norman D. Jr.
12/10
10:32 am
wst
Form 3 WEST PHARMACEUTICAL SERV For: Dec 09 Filed by: Finch Norman D. Jr.
Low
Report
Form 3 WEST PHARMACEUTICAL SERV For: Dec 09 Filed by: Finch Norman D. Jr.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/23
Q1/2020 3/31/2020 EPS 1.010 ZacksConsensus 0.820 ActVsEst 0.190 - Beat
11.9%
7/25 Q2/2019 6/30/2019 EPS 0.890 ZacksConsensus 0.720 ActVsEst 0.170 - Beat 9.1%
2/13 Q4/2019 12/31/2019 EPS 0.820 ZacksConsensus 0.720 ActVsEst 0.100 - Beat 7.0%
4/24 West Pharmaceutical Services Inc. (NYSE: WST) was upgraded by analysts at Bank of America Corp from an "underperform" rating to a "neutral" rating. 4.6%
3/13 Form PRE 14A WEST PHARMACEUTICAL SERV For: May 05 4.5%
3/2 Form 4 WEST PHARMACEUTICAL SERV For: Feb 26 Filed by: Abraham Silji 3.9%
7/25 West Pharmaceutical Services's (WST) CEO Eric Green on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.0%
4/2 Form 4 WEST PHARMACEUTICAL SERV For: Mar 31 Filed by: ZENNER PATRICK J 1.9%
10/3 West Pharmaceutical Services Inc. (NYSE: WST) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 1.9%
10/25 West Pharmaceutical Services (WST) Q3 2019 Earnings Call Transcript [The Motley Fool] 1.8%
7/25 Q2/2019 6/30/2019 EPS 0.890 ZacksConsensus 0.720 ActVsEst 0.170 - Beat 9.1%
2/13 Q4/2019 12/31/2019 EPS 0.820 ZacksConsensus 0.720 ActVsEst 0.100 - Beat 7.0%
4/24 West Pharmaceutical Services Inc. (NYSE: WST) was upgraded by analysts at Bank of America Corp from an "underperform" rating to a "neutral" rating. 4.6%
3/13 Form PRE 14A WEST PHARMACEUTICAL SERV For: May 05 4.5%
3/2 Form 4 WEST PHARMACEUTICAL SERV For: Feb 26 Filed by: Abraham Silji 3.9%
7/25 West Pharmaceutical Services's (WST) CEO Eric Green on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.0%
4/2 Form 4 WEST PHARMACEUTICAL SERV For: Mar 31 Filed by: ZENNER PATRICK J 1.9%
10/3 West Pharmaceutical Services Inc. (NYSE: WST) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 1.9%
10/25 West Pharmaceutical Services (WST) Q3 2019 Earnings Call Transcript [The Motley Fool] 1.8%
TOP News Decliners
2/25
West Announces Second-Quarter Dividend
-2.6%
10/24 Q3/2019 9/30/2019 EPS 0.790 ZacksConsensus 0.710 ActVsEst 0.080 - Beat -2.2%
2/24 Form 10-K WEST PHARMACEUTICAL SERV For: Dec 31 -1.9%
4/28 Form 4 WEST PHARMACEUTICAL SERV For: Apr 24 Filed by: Green Eric Mark -1.8%
8/23 West Announces Participation in Upcoming September Investor Conferences -1.7%
8/3 West Pharmaceutical Services Inc. (NYSE: WST) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $158.00 price target on the stock. -1.6%
2/27 Form 3 WEST PHARMACEUTICAL SERV For: Feb 17 Filed by: FRIEL ROBERT F -1.5%
4/30 Form 4 WEST PHARMACEUTICAL SERV For: Apr 28 Filed by: Abraham Silji -1.4%
10/16 West Increases Equity Stake in Daikyo Seiko, Ltd. - Extending the Companies' Longstanding Partnership in Injectable Drug Delivery -1.3%
4/9 West to Host First-Quarter 2020 Conference Call -1.1%
10/24 Q3/2019 9/30/2019 EPS 0.790 ZacksConsensus 0.710 ActVsEst 0.080 - Beat -2.2%
2/24 Form 10-K WEST PHARMACEUTICAL SERV For: Dec 31 -1.9%
4/28 Form 4 WEST PHARMACEUTICAL SERV For: Apr 24 Filed by: Green Eric Mark -1.8%
8/23 West Announces Participation in Upcoming September Investor Conferences -1.7%
8/3 West Pharmaceutical Services Inc. (NYSE: WST) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "strong-buy" rating. They now have a $158.00 price target on the stock. -1.6%
2/27 Form 3 WEST PHARMACEUTICAL SERV For: Feb 17 Filed by: FRIEL ROBERT F -1.5%
4/30 Form 4 WEST PHARMACEUTICAL SERV For: Apr 28 Filed by: Abraham Silji -1.4%
10/16 West Increases Equity Stake in Daikyo Seiko, Ltd. - Extending the Companies' Longstanding Partnership in Injectable Drug Delivery -1.3%
4/9 West to Host First-Quarter 2020 Conference Call -1.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: